Atomo Diagnostics Limited (ASX:AT1)
Australia
· Delayed Price · Currency is AUD 0.0140
0.00 (0.00%)
Jul 1, 2025, 4:10 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 9.61 million as of June 30, 2025. Its market cap has decreased by -48.18% in one year.
Market Cap
9.61M
Enterprise Value
6.91M
Revenue
4.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 9.61M, a decrease of -95.61%. That is a compound annual growth rate of -45.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 9.61M | -20.91% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | 172.45M | -21.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 115.96B |
| Pro Medicus | 29.78B |
| Cochlear | 19.65B |
| Sonic Healthcare | 12.86B |
| Ramsay Health Care | 8.43B |
| Telix Pharmaceuticals | 8.26B |
| Ansell | 4.39B |
| Regis Healthcare | 2.36B |